FR2405066A1 - Compositions a liberation reglee pour l'administration d'agents therapeutiques a des ruminants - Google Patents

Compositions a liberation reglee pour l'administration d'agents therapeutiques a des ruminants

Info

Publication number
FR2405066A1
FR2405066A1 FR7815595A FR7815595A FR2405066A1 FR 2405066 A1 FR2405066 A1 FR 2405066A1 FR 7815595 A FR7815595 A FR 7815595A FR 7815595 A FR7815595 A FR 7815595A FR 2405066 A1 FR2405066 A1 FR 2405066A1
Authority
FR
France
Prior art keywords
ruminants
administration
therapeutic agents
release compositions
rumen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7815595A
Other languages
English (en)
Other versions
FR2405066B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Commonwealth Scientific and Industrial Research Organization CSIRO
Original Assignee
Commonwealth Scientific and Industrial Research Organization CSIRO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commonwealth Scientific and Industrial Research Organization CSIRO filed Critical Commonwealth Scientific and Industrial Research Organization CSIRO
Publication of FR2405066A1 publication Critical patent/FR2405066A1/fr
Application granted granted Critical
Publication of FR2405066B1 publication Critical patent/FR2405066B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0068—Rumen, e.g. rumen bolus

Landscapes

  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Feed For Specific Animals (AREA)

Abstract

La présente invention est relative à une composition à libération réglée destinée à administrer des agents actifs à des ruminants, caractérisée en ce que, lorsqu'elle est mélangée avec l'agent actif, son point de fusion est supérieur à 39 degrés C et lorsqu'on l'introduit sous forme d'un corps solide dans la panse d'un ruminant, elle est capable de se désintégrer lentement à l'interface entre ladite composition et le fluide ruminai présent dans la panse de l'animal.
FR7815595A 1977-05-25 1978-05-25 Compositions a liberation reglee pour l'administration d'agents therapeutiques a des ruminants Granted FR2405066A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPD023077 1977-05-25

Publications (2)

Publication Number Publication Date
FR2405066A1 true FR2405066A1 (fr) 1979-05-04
FR2405066B1 FR2405066B1 (fr) 1982-07-30

Family

ID=3767023

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7815595A Granted FR2405066A1 (fr) 1977-05-25 1978-05-25 Compositions a liberation reglee pour l'administration d'agents therapeutiques a des ruminants

Country Status (8)

Country Link
US (1) US4251506A (fr)
AU (1) AU520409B2 (fr)
CA (1) CA1107197A (fr)
DE (1) DE2822832A1 (fr)
FR (1) FR2405066A1 (fr)
GB (1) GB1603970A (fr)
NZ (1) NZ187228A (fr)
ZA (1) ZA782897B (fr)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ197543A (en) * 1980-07-02 1984-12-14 Commw Scient Ind Res Org Controlled release compositions for inclusion in intraruminal devices
NZ200714A (en) * 1981-06-24 1984-12-14 May & Baker Ltd Bolus comprising active material on bobbin for delivery to rumen
US4416659A (en) * 1981-11-09 1983-11-22 Eli Lilly And Company Sustained release capsule for ruminants
GB8328916D0 (en) * 1983-10-28 1983-11-30 Castex Prod Pharmaceutical pellet
US4649042A (en) * 1984-05-31 1987-03-10 Eli Lilly And Company Rumen delivery device
NZ212100A (en) * 1984-06-02 1988-07-28 Castex Prod Rumen bolus; outer casing sheds in segments
US4883484A (en) * 1986-06-17 1989-11-28 Shepherd Michael T Delivery device
AU591297B2 (en) * 1986-07-15 1989-11-30 Pitman-Moore Australia Limited Intra-ruminal depot
US4940465A (en) * 1987-05-27 1990-07-10 Felix Theeuwes Dispenser comprising displaceable matrix with solid state properties
US4892778A (en) * 1987-05-27 1990-01-09 Alza Corporation Juxtaposed laminated arrangement
US5499979A (en) * 1987-06-25 1996-03-19 Alza Corporation Delivery system comprising kinetic forces
US5110597A (en) * 1987-06-25 1992-05-05 Alza Corporation Multi-unit delivery system
US5023088A (en) * 1987-06-25 1991-06-11 Alza Corporation Multi-unit delivery system
US4957494A (en) * 1987-06-25 1990-09-18 Alza Corporation Multi-layer delivery system
US4874388A (en) * 1987-06-25 1989-10-17 Alza Corporation Multi-layer delivery system
US4876093A (en) * 1987-07-02 1989-10-24 Alza Corporation Dispenser with dispersing member for delivering beneficial agent
US4915949A (en) * 1987-07-13 1990-04-10 Alza Corporation Dispenser with movable matrix comprising a plurality of tiny pills
US4824675A (en) * 1987-07-13 1989-04-25 Alza Corporation Dispenser with movable matrix comprising a plurality of tiny pills
US5002772A (en) * 1988-05-31 1991-03-26 Pfizer Inc. Gastric retention system for controlled drug release
OA09249A (fr) * 1988-12-19 1992-06-30 Lilly Co Eli Composés de macrolides.
US5273752A (en) * 1989-07-18 1993-12-28 Alza Corporation Controlled release dispenser comprising beneficial agent
ES2141088T3 (es) * 1990-02-16 2000-03-16 Hoffmann La Roche Mejoras en la especificidad y conveniencia de la reaccion en cadena de la polimerasa.
US5198222A (en) * 1990-08-31 1993-03-30 Agribiotech, Inc. Time release bolus
US5240713A (en) * 1991-09-27 1993-08-31 Alza Corporation Dual rate agent delivery device
US5462741A (en) * 1992-08-06 1995-10-31 Alza Corporation High agent loaded controlled release dispenser
US5565339A (en) * 1992-10-08 1996-10-15 Hoffmann-La Roche Inc. Compositions and methods for inhibiting dimerization of primers during storage of polymerase chain reaction reagents
US5591606A (en) * 1992-11-06 1997-01-07 Dowelanco Process for the production of A83543 compounds with Saccharopolyspora spinosa
AU677041B2 (en) * 1993-02-19 1997-04-10 Commonwealth Scientific And Industrial Research Organisation Ecdysones used to improve productivity of ruminants
AU685107B2 (en) * 1993-03-12 1998-01-15 Dow Agrosciences Llc New A83543 compounds and process for production thereof
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
WO1996029025A1 (fr) * 1995-03-23 1996-09-26 Advanced Animal Technology Limited Dispositif d'administration d'une substance
US6962579B2 (en) * 1995-03-23 2005-11-08 Advanced Animal Technology Limited Substance delivery device
US6395292B2 (en) 1996-02-02 2002-05-28 Alza Corporation Sustained delivery of an active agent using an implantable system
US6001981A (en) * 1996-06-13 1999-12-14 Dow Agrosciences Llc Synthetic modification of Spinosyn compounds
US6245042B1 (en) 1997-08-27 2001-06-12 Science Incorporated Fluid delivery device with temperature controlled energy source
US6416782B1 (en) 2001-05-31 2002-07-09 Pacific Trace Minerals, Inc. Selenium bolus for ruminants
AUPR839001A0 (en) * 2001-10-19 2001-11-15 Eli Lilly And Company Dosage form, device and methods of treatment
DE10156453A1 (de) * 2001-11-16 2003-05-28 Westfalia Landtechnik Gmbh Verfahren und Einrichtung zur Bestimmung des Gesundheitsstatus von Tieren
US8360327B2 (en) * 2002-02-14 2013-01-29 Ensid Investments Ltd. Animal transponder tag
AU2011213734A1 (en) * 2004-09-09 2011-09-08 Argenta Manufacturing Limited Delivery Devices And Their Uses
US7538652B2 (en) * 2006-08-29 2009-05-26 International Business Machines Corporation Electrical component tuned by conductive layer deletion
DK3727555T3 (da) * 2017-12-18 2023-06-26 Biograil ApS Oral delivery of active drug substances
BR112021004458A2 (pt) * 2018-09-10 2021-05-25 Argenta Innovation Limited formulações de liberação controlada em dispositivos de distribuição
SI4013348T1 (sl) * 2019-08-14 2024-05-31 Elanco Tiergesundheit Ag Nov ščitnik za krila za krilato kapsulo in način njegove uporabe
LT4037666T (lt) 2020-12-08 2024-06-10 Ruminant Biotech Corp Limited Medžiagų pristatymo gyvūnams prietaisų ir būdų patobulinimai

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2895880A (en) * 1955-05-13 1959-07-21 Smith Kline French Lab Sustained release pharmaceutical product
FR1302362A (fr) * 1959-10-23 1962-08-31 Olin Mathieson Procédé pour la préparation de pilules à libération temporisée
US3147187A (en) * 1962-09-10 1964-09-01 Don Hall Lab Sustained release pharmaceutical
GB1002211A (en) * 1962-06-12 1965-08-25 William Eric Gaunt Method of preparing sustained release pharmaceutical tablets
FR1416304A (fr) * 1961-10-10 1965-11-05 Smith Kline French Lab Perfectionnements apportés aux tablettes et comprimés renfermant une importante quantité d'ingrédient actif libéré pendant un laps de temps prolongé, et aux procédés pour leur préparation
US3344029A (en) * 1963-06-03 1967-09-26 U S Ethicals Inc Sustained release composition
FR2070141A1 (fr) * 1969-10-17 1971-09-10 Hoechst Ag
US3773921A (en) * 1971-11-15 1973-11-20 Hoffmann La Roche Therapeutic compositions
GB1443923A (en) * 1972-05-02 1976-07-28 Shepard M Sustained release compositions

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE876033C (de) * 1949-06-14 1953-05-07 Nopco Chemical Company Verfahren zur Herstellung von haltbaren, fettloesliche Vitamine enthaltenden Trockenpraeparaten, insbesondere zur Verwendung in Futtermitteln
BE562124A (fr) * 1956-11-05
US4132753A (en) * 1965-02-12 1979-01-02 American Cyanamid Company Process for preparing oral sustained release granules
US3535419A (en) * 1965-12-15 1970-10-20 Syntex Corp Veterinary compositions and methods
US3374146A (en) * 1966-04-18 1968-03-19 American Cyanamid Co Sustained release encapsulation
NL6808619A (fr) * 1968-06-19 1969-12-23
US3538215A (en) * 1969-06-13 1970-11-03 Allied Chem Stabilized antibiotic in liquid ruminant feed supplement
AU449029B2 (en) * 1969-08-28 1974-04-17 Commonwealth Scientific And Industrial Research Organisation Device for administration to ruminants
US3857933A (en) * 1969-10-17 1974-12-31 Hoechst Ag Process for the manufacture of a drug dosage form permitting controlled release of active ingredient
FR2083622B1 (fr) * 1970-03-27 1975-08-22 Sankyo Co
US3696189A (en) * 1970-05-18 1972-10-03 Frank M Snyder Stabilized antibiotic and method
US3655864A (en) * 1970-09-21 1972-04-11 Smith Kline French Lab Glyceryl tristerate and higher fatty acid mixture for improving digestive absorption
US3959493A (en) * 1971-03-17 1976-05-25 Rumen Chemie, Ag Rumen bypass products comprising biologically active substances protected with aliphatic fatty acids
AU470538B2 (en) * 1972-05-15 1976-03-18 Commonwealth Scientific And Industrial Research Organisation Magnesium capsules

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2895880A (en) * 1955-05-13 1959-07-21 Smith Kline French Lab Sustained release pharmaceutical product
FR1302362A (fr) * 1959-10-23 1962-08-31 Olin Mathieson Procédé pour la préparation de pilules à libération temporisée
FR1416304A (fr) * 1961-10-10 1965-11-05 Smith Kline French Lab Perfectionnements apportés aux tablettes et comprimés renfermant une importante quantité d'ingrédient actif libéré pendant un laps de temps prolongé, et aux procédés pour leur préparation
GB1002211A (en) * 1962-06-12 1965-08-25 William Eric Gaunt Method of preparing sustained release pharmaceutical tablets
US3147187A (en) * 1962-09-10 1964-09-01 Don Hall Lab Sustained release pharmaceutical
US3344029A (en) * 1963-06-03 1967-09-26 U S Ethicals Inc Sustained release composition
FR2070141A1 (fr) * 1969-10-17 1971-09-10 Hoechst Ag
US3773921A (en) * 1971-11-15 1973-11-20 Hoffmann La Roche Therapeutic compositions
GB1443923A (en) * 1972-05-02 1976-07-28 Shepard M Sustained release compositions

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CA1975 *

Also Published As

Publication number Publication date
ZA782897B (en) 1979-05-30
FR2405066B1 (fr) 1982-07-30
CA1107197A (fr) 1981-08-18
AU3590878A (en) 1979-11-15
US4251506A (en) 1981-02-17
NZ187228A (en) 1981-02-11
DE2822832A1 (de) 1978-12-07
DE2822832C2 (fr) 1989-04-13
AU520409B2 (en) 1982-01-28
GB1603970A (en) 1981-12-02

Similar Documents

Publication Publication Date Title
FR2405066A1 (fr) Compositions a liberation reglee pour l'administration d'agents therapeutiques a des ruminants
ES2646087T3 (es) Ficotoxinas y sus usos.
EP1159957A3 (fr) Dispositif d'administration locale de formulations solides ou semi-solides, formulations retard pour administration parentérale et procédé de préparation
IT1246350B (it) Metodo per ottenere una rapida sospensione in acqua di farmaci insolubili
ATE432689T1 (de) Arzneimittelformulierungen mit verzögerter freisetzung mit einem trägerpeptid
AR037255A1 (es) Composiciones farmaceuticas que contienen oxibutinina
GB9401892D0 (en) Therapeutic agents
EP0217778A3 (en) Galenical forms for the sustained release of verapamil, their preparation and medicaments containing them
BRPI0501101A (pt) Dispositivo de cabeçote de fio dental com um meio de administração de agente de sabor
DK581685A (da) Transderimalt system for timolol-indgift
HUP0300882A2 (hu) Új önemulgeáló hatóanyag-beadási rendszer
FR2712807B1 (fr) Composition solide mucoadhésive, thérapeutique ou hygiénique, pour administration par application sur la muqueuse buccale ou nasale .
FR2678145B1 (fr) Compositions sous forme de pellets contenant des principes actifs non proteges vis a vis de la panse des ruminants associes a des principes actifs proteges contre la degradation dans la panse des ruminants.
ES8307496A1 (es) Procedimiento para la obtencion de una preparacion galenica antagonista al calcio.
KR830002510A (ko) 생물학적 활성화합물과 하이드록시알킬 전분으로 구성되는 조성물
ES2186207T3 (es) Metodo para preparacion de formulaciones farmaceuticas.
HUP0100580A2 (hu) Oldott paroxetint tartalmazó készítmények
SE8204288D0 (sv) Apap-anticidum-komposition
RU2180556C2 (ru) Гель-смазка (варианты)
DK295082A (da) Komposition til topisk legemanvendelse
GB1354263A (en) Therapeutic composition
JPS5441321A (en) Remedy for skin diseases and its preparation
Truhaut The toxicology of thallium
BE899277A (fr) Agents antimycotiques a haute liberation de substance active sous forme d'une solution et d'une pulverisation.
Iwatsuki et al. Effects of methylisobutylxanthine (MIX) on the secretion of pancreatic juice in the blood-perfused canine pancreas